(Reuters) - Pfizer Inc reported stronger-than-expected quarterly sales due to cost cuts and demand for its vaccines and cancer drugs, but the company forecast 2015 earnings below Wall Street expectations, citing patent expirations and the stronger dollar.
via Health News Headlines - Yahoo News Read More Here..
No comments:
Post a Comment